Medical Technology and Devices (MTD) is a leading innovator in the healthcare sector, headquartered in Italy. Established in 2005, the company has rapidly expanded its operational footprint across Europe and North America, focusing on advanced medical technologies and devices. MTD is renowned for its cutting-edge solutions in surgical instruments, diagnostic equipment, and patient monitoring systems, which are distinguished by their precision and reliability. With a commitment to enhancing patient outcomes, MTD has achieved significant milestones, including several industry awards for innovation and quality. The company holds a strong market position, recognised for its contributions to improving healthcare delivery. MTD continues to push the boundaries of medical technology, ensuring that healthcare professionals have access to the best tools available.
How does Medical Technology And Devices's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Medical Technology And Devices's score of 19 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Medical Technology And Devices reported total carbon emissions of approximately 44,830,000 kg CO2e. This figure includes 4,483,000 kg CO2e from Scope 1 emissions, which encompass direct emissions from owned or controlled sources, and 18,395,000 kg CO2e from Scope 2 emissions, related to indirect emissions from the generation of purchased electricity. Scope 3 emissions, which cover all other indirect emissions, accounted for about 48,358,000 kg CO2e. Over the years, the company has shown a trend of reducing its emissions. For instance, in 2022, total emissions were approximately 64,289,000 kg CO2e, indicating a significant reduction in emissions in 2023. The company has not publicly committed to specific reduction targets or initiatives, nor does it appear to have set Science-Based Targets Initiative (SBTi) reduction targets. The emissions data reflects a commitment to monitoring and potentially reducing carbon footprints, although specific climate pledges or detailed reduction strategies have not been disclosed. The company operates within the medical technology sector, which is increasingly focusing on sustainability and climate responsibility.
Access structured emissions data, company-specific emission factors, and source documents
Add to project2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|
Scope 1 | 2,973,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
Scope 2 | 35,327,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 3 | 10,858,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medical Technology And Devices is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.